|
(11) | EP 0 704 057 A1 |
| (12) |
|
|
|
|
|||||||||||||||||||
| (54) | NOVEL CLINICAL MARKER AND THERAPEUTIC AGENT IN KIDNEY STONE DISEASE AND METHODS OF USE |